ID
13138
Description
Alemtuzumab (CAMPATH 1H) Associated to G-CSF in Adult Patients With Refractory Acute Lymphocytic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00773149
Link
https://clinicaltrials.gov/show/NCT00773149
Keywords
Versions (1)
- 1/19/16 1/19/16 -
Copyright Holder
CC BY-NC 3.0
Uploaded on
January 19, 2016
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Acute Lymphocytic Leukemia NCT00773149
Eligibility Acute Lymphocytic Leukemia NCT00773149
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
children below 15 years of age or aged 15
Data type
boolean
Alias
- UMLS CUI [1]
- C0001779
Description
blast cells not expressing cd52 antigen
Data type
boolean
Alias
- UMLS CUI [1]
- C1267944
Description
HIV
Data type
boolean
Alias
- UMLS CUI [1]
- C0019682
Description
ECOG score
Data type
boolean
Alias
- UMLS CUI [1]
- C1520224
Description
hypersensitivity to alemtuzumab
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0383429
Description
pregnancy or breast feeding
Data type
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Description
malignancy
Data type
boolean
Alias
- UMLS CUI [1]
- C0006826
Similar models
Eligibility Acute Lymphocytic Leukemia NCT00773149
- StudyEvent: Eligibility
C0472699 (UMLS CUI [2])
C0383429 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])